Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England
© 2023. The Author(s)..
As the SARS-CoV-2 pandemic progressed, distinct variants emerged and dominated in England. These variants, Wildtype, Alpha, Delta, and Omicron were characterized by variations in transmissibility and severity. We used a robust mathematical model and Bayesian inference framework to analyse epidemiological surveillance data from England. We quantified the impact of non-pharmaceutical interventions (NPIs), therapeutics, and vaccination on virus transmission and severity. Each successive variant had a higher intrinsic transmissibility. Omicron (BA.1) had the highest basic reproduction number at 8.3 (95% credible interval (CrI) 7.7-8.8). Varying levels of NPIs were crucial in controlling virus transmission until population immunity accumulated. Immune escape properties of Omicron decreased effective levels of immunity in the population by a third. Furthermore, in contrast to previous studies, we found Alpha had the highest basic infection fatality ratio (2.9%, 95% CrI 2.7-3.2), followed by Delta (2.2%, 95% CrI 2.0-2.4), Wildtype (1.2%, 95% CrI 1.1-1.2), and Omicron (0.7%, 95% CrI 0.6-0.8). Our findings highlight the importance of continued surveillance. Long-term strategies for monitoring and maintaining effective immunity against SARS-CoV-2 are critical to inform the role of NPIs to effectively manage future variants with potentially higher intrinsic transmissibility and severe outcomes.
| Errataetall: |
ErratumIn: Nat Commun. 2023 Dec 7;14(1):8099. - PMID 38062038 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Nature communications - 14(2023), 1 vom: 17. Juli, Seite 4279 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Perez-Guzman, Pablo N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 19.07.2023 Date Revised 14.02.2024 published: Electronic ErratumIn: Nat Commun. 2023 Dec 7;14(1):8099. - PMID 38062038 Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-023-39661-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359610919 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359610919 | ||
| 003 | DE-627 | ||
| 005 | 20240214232734.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-023-39661-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1292.xml |
| 035 | |a (DE-627)NLM359610919 | ||
| 035 | |a (NLM)37460537 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Perez-Guzman, Pablo N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.07.2023 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumIn: Nat Commun. 2023 Dec 7;14(1):8099. - PMID 38062038 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a As the SARS-CoV-2 pandemic progressed, distinct variants emerged and dominated in England. These variants, Wildtype, Alpha, Delta, and Omicron were characterized by variations in transmissibility and severity. We used a robust mathematical model and Bayesian inference framework to analyse epidemiological surveillance data from England. We quantified the impact of non-pharmaceutical interventions (NPIs), therapeutics, and vaccination on virus transmission and severity. Each successive variant had a higher intrinsic transmissibility. Omicron (BA.1) had the highest basic reproduction number at 8.3 (95% credible interval (CrI) 7.7-8.8). Varying levels of NPIs were crucial in controlling virus transmission until population immunity accumulated. Immune escape properties of Omicron decreased effective levels of immunity in the population by a third. Furthermore, in contrast to previous studies, we found Alpha had the highest basic infection fatality ratio (2.9%, 95% CrI 2.7-3.2), followed by Delta (2.2%, 95% CrI 2.0-2.4), Wildtype (1.2%, 95% CrI 1.1-1.2), and Omicron (0.7%, 95% CrI 0.6-0.8). Our findings highlight the importance of continued surveillance. Long-term strategies for monitoring and maintaining effective immunity against SARS-CoV-2 are critical to inform the role of NPIs to effectively manage future variants with potentially higher intrinsic transmissibility and severe outcomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Knock, Edward |e verfasserin |4 aut | |
| 700 | 1 | |a Imai, Natsuko |e verfasserin |4 aut | |
| 700 | 1 | |a Rawson, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Elmaci, Yasin |e verfasserin |4 aut | |
| 700 | 1 | |a Alcada, Joana |e verfasserin |4 aut | |
| 700 | 1 | |a Whittles, Lilith K |e verfasserin |4 aut | |
| 700 | 1 | |a Thekke Kanapram, Divya |e verfasserin |4 aut | |
| 700 | 1 | |a Sonabend, Raphael |e verfasserin |4 aut | |
| 700 | 1 | |a Gaythorpe, Katy A M |e verfasserin |4 aut | |
| 700 | 1 | |a Hinsley, Wes |e verfasserin |4 aut | |
| 700 | 1 | |a FitzJohn, Richard G |e verfasserin |4 aut | |
| 700 | 1 | |a Volz, Erik |e verfasserin |4 aut | |
| 700 | 1 | |a Verity, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Ferguson, Neil M |e verfasserin |4 aut | |
| 700 | 1 | |a Cori, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Baguelin, Marc |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 14(2023), 1 vom: 17. Juli, Seite 4279 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2023 |g number:1 |g day:17 |g month:07 |g pages:4279 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-023-39661-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2023 |e 1 |b 17 |c 07 |h 4279 | ||